Successful Treatment of Autoimmune Hemolytic Anemia Concomitant with Proliferation of Epstein-Barr Virus in a Post-Heart Transplant Patient
Autoimmune hemolytic anemia (AIHA) is a rare complication following heart transplantation and has been attributed to several etiologies including infections, immunosuppressive medications, and post-transplant lymphoproliferative disorders. We report a 23-year-old male presenting 22 years after heart...
Main Authors: | Dan Ran Castillo, Parthiv Sheth, Kevin Nishino, Wesley Tait Stevens, Anthony Nguyen, Alberto Romagnolo, Hamid Mirshahidi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | https://www.mdpi.com/2038-8330/14/3/36 |
Similar Items
-
Is Splenectomy still the best treatment for Autoimmune hemolytic anemia
by: Malwina Chomicz, et al.
Published: (2023-08-01) -
Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
by: Francesco Autore, et al.
Published: (2021-11-01) -
A unique case series of pediatric autoimmune hemolytic anemia
by: Sanghamitra Ray, et al.
Published: (2024-06-01) -
Sepsis-induced autoimmune hemolytic anemia in the elderly
by: D Thangam, et al.
Published: (2022-01-01) -
Evaluation of hepatic toxicity in autoimmune hemolytic anemia (AIHA) and Evans syndrome patients: a single-center Egyptian study
by: Fatma Abozeid, et al.
Published: (2024-02-01)